Renowned Everest guide says using xenon speeds climb and makes it safer, better for environment
Lukas Furtenbach took a team of British climbers, who left London on May 16, to scale the 8,849-meter (29,032-foot) peak on May 21. They returned home two days later, in one of the fastest ascents on record of the world's highest peak, including the climbers' travel from their homes and back.
The use of xenon gas treatment has, however, drawn controversy and has even raised the concerns of Nepalese mountaineering authorities who have announced an investigation.
'The only reason why we are working with xenon is to make climbing safer, to protect climbers from high altitude sickness,' Furtenbach told The Associated Press upon his return to Kathmandu. 'We can see people dying on Everest every year and this is may be one step to improve the situation to make climbing high altitude mountains safer.'
The climbers had put in months of preparation, training in hypoxia tents, and underwent a xenon gas treatment at a clinic in Germany just two weeks before heading to Nepal.
Climbers normally spend weeks at base camp to acclimatize to the higher altitude. They make practice runs to the lower camps on Everest before beginning their final attempt on the peak so that their bodies are prepared for the low pressure and lower level of oxygen available.
The new method is likely to reduce the time climbers spend out of their home countries and cut the number of days they need to take off work, also cutting down on expenses.
Furtenbach said the ability to climb the peak in a short period of time could also lead to less environmental impact on the mountain.
'Human waste is one of the biggest problems on Everest base camp. If people spend one week there compared to eight weeks, it is a 75 precent reduction of human waste," he said. "It is a huge reduction of garbage on the mountain and also of resources that have to be carried up to the back camp and have to be carried up the mountain.'
Nepal doesn't have rules on how many days climbers must spend acclimatizing or making practice climbs. The permits to climb Everest, which cost $11,000 each, are valid for 90 days. Climbing season normally wraps up by the end of May, when the weather deteriorates and monsoon season begins. The ropes and ladders fixed to the mountain are then pulled out.
Nepal's mountaineering department issued a press statement saying it was going to investigate the use of xenon gas.
Furtenbach said the gas was never used in Nepal and that he could prove that it was safe to use for climbers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
a day ago
- The Independent
Breakthrough discovery could slow or reverse Parkinson's disease
A new study suggests that a low-oxygen environment, similar to the air around Mount Everest 's base camp, could be key to treating and potentially reversing Parkinson's disease. Research indicates that Parkinson's symptoms are linked to an accumulation of excess oxygen molecules in the brain, caused by dysfunctional cellular processes. In experiments, mice with Parkinson's-like conditions housed in low-oxygen chambers did not experience neuron loss or movement problems, despite developing protein clumps. The findings suggest that reducing overall oxygen supply protects brain cells from damage, even if it does not prevent the formation of toxic protein clumps. Scientists are now working on "hypoxia in a pill" drugs to mimic these low-oxygen effects, though further research is required before human application. 'Mount Everest air' could hold key to reversing Parkinson's symptoms, study finds
The Independent
a day ago
- The Independent
‘Mount Everest air' could hold key to reversing Parkinson's symptoms, study finds
A low- oxygen environment similar to the air around Mount Everest 's base camp could be key to tackling and even reversing Parkinson's disease, a new study suggests. The research, published in the journal Nature Neuroscience, shows that faulty cellular processes in the brain cause a build-up of excess oxygen molecules, leading to Parkinson's symptoms. The excess oxygen appears to drive the breakdown of cells in the brain, suggesting that limiting oxygen intake could help slow or reverse symptoms, say researchers from Harvard Medical School. Parkinson's patients experience a progressive loss of neurons in the brain, leading to tremors and slowed movements, with the disease affecting over 10 million people worldwide. Neurons affected by Parkinson's also tend to accumulate toxic protein clumps called Lewy bodies, with some research suggesting that these clumps interfere with the function of mitochondria, the powerhouse of the cell, . Anecdotal case studies have shown that people with Parkinson's seem to fare better at high altitudes. 'Based on this evidence, we became very interested in the effect of hypoxia on Parkinson's disease,' said study author Fumito Ichinose. 'We first saw that low oxygen could alleviate brain-related symptoms in some rare diseases where mitochondria are affected, such as Leigh syndrome and Friedreich's ataxia... That raised the question: Could the same be true in more common neurodegenerative diseases like Parkinson's?' said Vamsi Mootha, another author of the study. In the research, scientists induced Parkinson's-like conditions in mice by injecting them with clumps of the α-synuclein proteins that seed the formation of Lewy bodies. They then split the mice into two groups – one breathing normal air with 21 per cent oxygen, and the other continuously housed in chambers with 11 per cent oxygen, comparable to living at an altitude of about 4,800 metres (16,000 ft). Researchers found that just three months after receiving the α-synuclein protein injections, mice breathing normal air had high levels of Lewy bodies, dead neurons, and severe movement problems. On the other hand, the mice kept in low-oxygen conditions didn't lose any neurons and showed no movement problems, despite developing Lewy bodies. The results show that while hypoxia couldn't stop the formation of Lewy bodies, it was protecting neurons from the damaging effects of these protein clumps. Researchers hope the findings could serve as a new way to interpret and treat Parkinson's without targeting α-synuclein or Lewy bodies. Scientists also found that the low-oxygen treatment still worked even when hypoxia was introduced six weeks after the injection, when symptoms were already appearing. After six weeks, the mice's motor skills rebounded, their anxiety-like behaviours faded, and the loss of neurons in the brain stopped, researchers found. When scientists analysed the brain cells of the mice, they discovered that mice with Parkinson's symptoms had much higher levels of oxygen in some parts of the brain than control mice and those that had breathed low-oxygen air. They suspect the excess oxygen likely resulted from mitochondrial dysfunction. With the damaged cell powerhouses unable to use oxygen efficiently, oxygen was building up to damaging levels, researchers say. 'Too much oxygen in the brain turns out to be toxic. By reducing the overall oxygen supply, we're cutting off the fuel for that damage,' Dr Mootha said. Scientists are working on 'hypoxia in a pill' drugs which mimic the effects of low oxygen to treat disorders stemming from mitochondrial dysfunction. But while the results are encouraging, researchers caution that more research is needed before the findings can be directly used to treat Parkinson's in humans. 'It may not be a treatment for all types of it's a powerful concept – one that might shift how we think about treating some of these diseases,' Dr Mootha said.
The Independent
3 days ago
- The Independent
Pakistan will not restrict mountaineering expeditions despite the recent deaths of climbers
Pakistan has issued no warnings or restrictions for mountaineering expeditions in the north, an official said Sunday, despite the recent deaths of climbers. Climbers were well aware of the harsh weather and all the other risks and challenges, said Faizullah Faraq, a spokesman for the government of Gilgit-Baltistan, the northern region home to some of the world's highest mountains. 'Despite that, they willingly accept these challenges and come here to attempt these summits.' Chinese climber Guan Jing, 37, was the latest person to perish on one of Pakistan's mountains. She died last Tuesday after being hit by falling rocks on K2, the world's second-highest peak known for its treacherous slopes and extreme weather conditions. Rescue teams recovered her body on Saturday. Her body was still in the mortuary of the Combined Military Hospital in Skardu on Sunday. Contact has been made with Chinese authorities in Islamabad, and 'now it is up to them to make further decisions in this regard,' said Faraq. Jing's death occurred several weeks after German mountaineer and Olympic gold medalist Laura Dahlmeier died while attempting Laila Peak in the Karakoram mountain range. Bodies of foreign climbers who die attempting to summit mountains in Pakistan are typically recovered at the request of their families. But if the family declines a rescue, the remains are left at the spot where the climber died. Faraq said authorities were trying to provide climbers with better infrastructure, rescue facilities, security and a friendly environment. Mountaineering expeditions are the backbone of the local economy, bringing in millions of dollars in direct revenue. A large number of people work on these expeditions from May to September, feeding their families for the whole year with these earnings, he added. Hundreds of climbers try to scale mountains in northern Pakistan every year. Accidents are common because of avalanches and sudden weather changes. Last August, two Russians spent six days stranded on a remote peak before they were rescued. Gilgit-Baltistan, in Kashmir, has been battered by higher-than-normal monsoon rains this year, triggering flash floods and landslides.
